Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Los Angeles, California

Phase 2 colorectal cancer trials in Los Angeles, CA

12 Phase 2 colorectal cancer studies are recruiting participants at sites in Los Angeles as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Los Angeles at a glance

  • 12 studies are recruiting at a site in Los Angeles.
  • By phase: Phase 2 (12).
  • By sponsor: industry (11), university, hospital or other (1).
  • Most recent update to one of these records: November 18, 2026.

Studies recruiting in Los Angeles

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study sites
    Cedars-Sinai Medical Center · START Los Angeles · Valkyrie Clinical Trials (contact for more locations)
    Registry record
    NCT07659795 · updated
  2. Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Solstice Oncology, Inc.
    Registry record
    NCT07808151 · updated
  3. Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    Ellison Institute
    Registry record
    NCT04557449 · updated
  4. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Study sites
    Clinical Research Advisors (Downtown LA) · Clinical Research Advisors (West Hollywood)
    Registry record
    NCT07446322 · updated
  5. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Cedars-Sinai Medical Center
    Registry record
    NCT05673148 · updated
  6. Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Buzzard Pharmaceuticals
    Study site
    USC/Norris Cancer Center
    Registry record
    NCT06634875 · updated
  7. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    USC Norris Comprehensive Cancer Center /ID# 274550
    Registry record
    NCT07023289 · updated
  8. Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

    • Phase 2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05489211 · updated
  9. A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Ono Pharmaceutical Co., Ltd.
    Study site
    USC Norris Comprehensive Cancer Center
    Registry record
    NCT06948448 · updated
  10. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Study site
    Cedars-Sinai Medical Center
    Registry record
    NCT06937177 · updated
  11. An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NGM Biopharmaceuticals, Inc
    Study site
    NGM Clinical Study Site
    Registry record
    NCT07033026 · updated
  12. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Apollomics Inc.
    Study site
    Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute
    Registry record
    NCT03175224 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Ask about studies near Los Angeles

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call